Advice
Following an abbreviated submission.
Rabeprazole 10 mg and 20 mg tablet (Pariet) is accepted for use within NHS Scotland for the treatment of Zollinger-Ellison syndrome.
Other proton pump inhibitors are available for this indication at a lower cost per treatment period.
Download detailed advice28KB (PDF)
Medicine details
- Medicine name:
- Rabeprazole 10 mg and 20 mg tablet (Pariet®)
- SMC ID:
- 232/06
- Indication:
- Zollinger-Ellison syndrome
- Pharmaceutical company
- Eisai Ltd
- BNF chapter
- Gastro-intestinal system
- Submission type
- Abbreviated
- Status
- Accepted
- Date advice published
- 13 February 2006